A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: Rocatinlimab
- OTHER: Placebo
Sponsor
Amgen